Cargando…
Priming mesenchymal stem cells with α-synuclein enhances neuroprotective properties through induction of autophagy in Parkinsonian models
BACKGROUND: Mesenchymal stem cells (MSCs) may be one of candidates for disease-modifying therapy in Parkinsonian diseases. As knowledge regarding the therapeutic properties of MSCs accumulates, some obstacles still remain to be overcome, especially, successful clinical translation requires the devel...
Autores principales: | Shin, Jin Young, Kim, Dong-Yeol, Lee, Jieun, Shin, Yu Jin, Kim, Yi Seul, Lee, Phil Hyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509608/ https://www.ncbi.nlm.nih.gov/pubmed/36153562 http://dx.doi.org/10.1186/s13287-022-03139-w |
Ejemplares similares
-
Priming mesenchymal stem cells with uric acid enhances neuroprotective properties in parkinsonian models
por: Kim, Ha Na, et al.
Publicado: (2021) -
Uric acid regulates α-synuclein transmission in Parkinsonian models
por: Shin, Yu Jin, et al.
Publicado: (2023) -
The Cleavage Effect of Mesenchymal Stem Cell and Its Derived Matrix Metalloproteinase‐2 on Extracellular α‐Synuclein Aggregates in Parkinsonian Models
por: Oh, Se Hee, et al.
Publicado: (2016) -
Uric Acid Enhances Neurogenesis in a Parkinsonian Model by Remodeling Mitochondria
por: Lee, Ji Eun, et al.
Publicado: (2022) -
Mechanism of neuroprotection by trehalose: controversy surrounding autophagy induction
por: Lee, He-Jin, et al.
Publicado: (2018)